Antimicrobial resistance and diabetes mellitus represent two national and international health problems. ACCP’s Clinical Reasoning Series programs, to be offered in conjunction with the 2012 Annual Meeting, will discuss the challenges faced with both and offer the clinical pharmacist strategies to manage them by providing evidence-based, safe, and cost-effective services.

From Theory to Bedside: Clinical Reasoning Series and From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy are approved by the Board of Pharmacy Specialties for the recertification of the Board Certified Pharmacotherapy Specialist (BCPS) and the Board Certified Ambulatory Care Pharmacist (BCACP), respectively. Both programs will be offered Saturday, October 20, 2012. Each program will provide 6.0 CPE credit hours that can be used toward pharmacy specialty recertification. To be eligible for recertification credits, the specialist must attend the pertinent live program and successfully complete the Web-based posttest for that program by November 30, 2012.

“Antimicrobial Resistance: Prevention and Management Strategies,” designed for the BCPS, will include the following sessions:

• Antimicrobial Resistance: Mechanisms and Emerging Patterns
• Genomics: Strategies Against Resistance Development and Therapeutic Implications
• Methicillin-Resistant Staphylococcus aureus: Microbiology and Clinical Evidence
• Vancomycin-Resistant Enterococcus Infections: Microbiology and Clinical Evidence
• Clostridium difficile Infections: Microbiology and Clinical Evidence
• Antimicrobial Stewardship: Lessons Learned and New Opportunities
• Formulary and Pharmacoeconomic Considerations

“New and Emerging Therapies for the Management of Type 2 Diabetes Mellitus,” designed for the BCACP, will include the following sessions:

• The Science of Diabetes Medications
• New and Emerging Antidiabetic Agents—Scientific and Clinical Evidence
• Management Guidelines—Integrating New Therapeutic Strategies
• Medication Safety—Clinical Considerations and Impact on Health Care
• Formulary and Pharmacoeconomic Considerations
• Pharmacist Services—Patient Outcomes and Best Practices

More information about the antimicrobial resistance program, including target audience, CPE and BCPS recertification credit, learning objectives, agenda, program faculty, and registration, may be found at http://www.accp.com/announcements/crsph.aspx. More information about the diabetes mellitus program, including target audience, CPE and BCACP recertification credit, activity goals, agenda, program faculty, and registration, may be found at http://www.accp.com/announcements/crsam.aspx.